Mark Enyedy – Biography
Last update: January 26, 2026Executive profile
Mark was Executive Vice President and Head of Corporate Development at Shire Pharmaceuticals, and Chief Executive Officer at Proteostasis Therapeutics. Mark Enyedy joined Ergomed in 2025.
Mark Enyedy is currentlyDirector at Biomarin Pharmaceutical - View - Biomarin Pharmaceutical org chart
Director at Charles River Laboratories - View - Charles River Laboratories org chart
Independent Director at Ergomed - View - Ergomed org chart
Outside Director at Astellas Pharma - View - Astellas Pharma org chart
Create your alert
to follow the career of Mark Enyedy.
Education
In 1990, Mark Enyedy completed a Juris Doctor at Harvard Law School.
They have also studied at Harvard Law School :
Find more alumni from Harvard Law School
More about Mark Enyedy
Selected links
Do you need to know more about Mark Enyedy? More results.
Participate
Social media
- Mark Enyedy on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Mark Enyedy
The colleagues of Mark Enyedy
Company Colleagues
- At Biomarin Pharmaceutical, Mark Enyedy has 59 colleagues including Alexander Hardy (CEO & President), Willard Dere (Director)…
- At Charles River Laboratories, Mark Enyedy has 35 colleagues including Birgit Girshick (CEO), Paul Graves (Director)…
- At Ergomed, Mark Enyedy has 36 colleagues including Sy Pretorius (CEO), Miroslav Reljanovic (Executive Chairman)…
- At Astellas Pharma, Mark Enyedy has 75 colleagues including Naoki Okamura (CEO & President), Kenji Yasukawa (Chairman of the Board)…
Industry Colleagues
- In the Healthcare industry, Mark Enyedy has 54,619 colleagues in 3,494 companies located in 59 countries. 39,488 executive movements have been recorded in the last 12 months. Learn more about Healthcare.
Report an error
Update the org chart details of Mark Enyedy.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Mark Enyedy.
